EUVIMEDScopri EUVIMED
Übersichtsarbeit

The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Dennis E Niewoehner

American Journal of Respiratory Medicine · 2002

DOI: 10.1007/bf03256615 ↗

At a glance

Übersichtsarbeit in American Journal of Respiratory Medicine, 2002. Written by Dennis E Niewoehner. Institution: Pulmonary Section, Veterans Affairs Medical Center, and University of Minnesota, Minneapolis, Minnesota 55417, USA. niewo001@umn.edu. Cited 30 times so far (Crossref); 37 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The administration of systemic corticosteroids for patients with exacerbations of chronic obstructive pulmonary disease (COPD) has become common practice over the past 25 years. This practice remained somewhat controversial because corticosteroids can have serious adverse effects and initial clinical trials provided inconclusive evidence concerning their efficacy. Results from recent clinical trials indicate that systemic corticosteroids are modestly effective in shortening the duration of severe exacerbations of COPD. Systemic corticosteroids administered intravenously or orally to hospitalized patients with exacerbations of COPD reduced the absolute treatment failure rate by about 10%, increased the forced expiratory volume in 1 second (FEV1) by about 100 ml, and shortened the hospital stay by 1 to 2 days. Oral corticosteroids probably confer similar benefits when used for treating moderately severe COPD exacerbations in an out-patient setting. The optimal starting dose of corticosteroids is not known, but the duration of treatment should not extend longer than 2 weeks. Hyperglycemia is the most common adverse event, but secondary infections, mental disturbances, and myopathies may also occur.

Subjects

MeSH terms (MEDLINE)

Acute DiseaseAdministration, OralAdrenal Cortex HormonesDrug Administration ScheduleHumansHydrocortisoneMethylprednisolonePrednisonePulmonary Disease, Chronic ObstructiveRandomized Controlled Trials as TopicRespiratory Function TestsSeverity of Illness Index

Substances

Adrenal Cortex HormonesPrednisoneHydrocortisoneMethylprednisolone

Authors and institutions

  • Pulmonary Section, Veterans Affairs Medical Center, and University of Minnesota, Minneapolis, Minnesota 55417, USA. niewo001@umn.edu

Cite

APA

Niewoehner, D. E. (2002). The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Medicine. https://doi.org/10.1007/bf03256615

Vancouver

Niewoehner DE. The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Medicine. 2002. doi:10.1007/bf03256615

BibTeX
@article{Niewoehner2002,
  author = {Niewoehner, Dennis E},
  title = {The Role of Systemic Corticosteroids in Acute Exacerbation of Chronic Obstructive Pulmonary Disease},
  journal = {American Journal of Respiratory Medicine},
  year = {2002},
  doi = {10.1007/bf03256615}
}
Start for free →